Scholar Rock

New Capabilities

Won first FDA approval with Isembyld

Patients with spinal muscular atrophy (SMA) have had drugs that keep motor neurons alive for a decade. None stopped the muscle wasting that defines advanced disease. On September 11, 2026, the FDA approved the first treatment built to do that.

Updated 1 hour ago